International Journal of Molecular Sciences, 2026
Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis

Zhao S., Xu F., Cui L. et al.

European Heart Journal, 2026
Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling

Morze J., Björnson E., Mi M. et al.

BMC Bioinformatics, 2026
Multi-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics

Cao L., Wang J., You S. et al.

Leukemia, 2026
TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy

Rappa G., Ziemann F., White K. et al.

Canadian Journal of Physiology and Pharmacology, 2026
Comparison of endothelin-1 levels in plasma from human coronary arteries measured by enzyme linked immunosorbent assay and Olink high-throughput proteomics platform

Anwar M., Kuc R., Bullock C. et al.

Medicine, 2026
Gut microbiota, inflammatory proteins, and allergic diseases

Zhu H., Dou M., Jin X.

Medicine, 2026
Causal link between polymyositis and idiopathic pulmonary fibrosis in individuals of European ancestry

Chen M., Tong X., Zhang R. et al.

Progress in Cardiovascular Diseases, 2026
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank

Cheon P., McParland J., Doherty S. et al.

American Journal of Preventive Cardiology, 2026
Proteome-wide association study of air pollution exposures in a high-risk cardiac catheterization cohort

Liu C., Roberts B., Patel M. et al.

Environmental Toxicology and Pharmacology, 2026
Integrated plasma proteomics and metabolomes reveal potential biomolecules linking PM2.5 to depression

Chen L., Zheng D., Wei S. et al.

Brain, Behavior, and Immunity, 2026
Doxorubicin administration modulates cancer-related fatigue in a time-of-day-dependent manner

Kastelein A., Kelters I., On A. et al.

Journal for ImmunoTherapy of Cancer, 2026
Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy

Haybout L., Kudling T., Clubb J. et al.

Molecular Biomedicine, 2026
Deletion of Pleiotrophin protects against high-fat diet-induced liver metabolic disease, independently of the sexual dimorphism in dietary response

Cañeque-Rufo H., Zuccaro A., Sanz-Cuadrado M. et al.

Alzheimer's & Dementia, 2026
Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes

Sim M., Hilal S., Tromp J. et al.

Atmospheric Environment, 2026
Long-term exposure to PM2.5, aging hallmarks, and age-related diseases: a nationwide prospective cohort study

Wang F., Luo J., Zhang Y. et al.

Nature Communications, 2026
Plasma proteomics defines two reproducible subphenotypes of sepsis-associated acute kidney injury with distinct outcomes

Legrand M., Nguyen H., Calfee C. et al.

RMD Open, 2026
Integration of synovial pathotypes and serum proteomic modules as determinants of disease progression and therapeutic response in early rheumatoid arthritis

Corrales S., Osuna-Soto J., Cid-Chaves A. et al.

Journal of Inflammation Research, 2026
Integrative Multi-Omics Mendelian Randomization Identifies BLMH as a Keratinocyte-Enriched Protective Candidate Gene and Potential Therapeutic Target in Psoriasis

Shen R., Ran B., Liu J. et al.

Frontiers in Immunology, 2026
The spatial landscape of the peritumoral interface: ARG1+ PMN-MDSCs reduction and NETosis as indicators of occult metastasis in tongue squamous cell carcinoma

Zhang S., Xu J., Zhang C. et al.

Ecotoxicology and Environmental Safety, 2026
Large-scale plasma proteomics identifies protein signatures linking air pollution to epilepsy

He Z., Yin J., Yang Q. et al.